Join Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 3 invites waiting! - Read the latest clinical news, personalized to your specialty.
Grant Support
- A macrocyclic peptide platform for the discovery of functional tau epitopesUNIVERSITY OF NOTRE DAME2025–2029
- XBP1 Inhibition and STING activation for the treatment of cancerMETHODIST HOSPITAL RESEARCH INSTITUTE2022–2027
- XBP1 Inhibition and STING activation for the treatment of cancerMETHODIST HOSPITAL RESEARCH INSTITUTE2022–2027
- XBP1 Inhibition and STING activation for the treatment of cancerMETHODIST HOSPITAL RESEARCH INSTITUTE2022–2027
- Chemical approaches to selectively target beta-rich amyloidosisUNIVERSITY OF NOTRE DAME2021–2026
- Chemical approaches to selectively target beta-rich amyloidosisUNIVERSITY OF NOTRE DAME2021–2026
- Chemical approaches to selectively target beta-rich amyloidosisUNIVERSITY OF NOTRE DAME2021–2026
- Chemical approaches to selectively target beta-rich amyloidosisUNIVERSITY OF NOTRE DAME2021–2026
- Chemical approaches to selectively target beta-rich amyloidosisUNIVERSITY OF NOTRE DAME2021–2026
- Synthesis Of New Ligands For The Characterization Of Siderophore-Exfabp InteractiNational Cancer Institute2007–2009
- Synthetic Methods Toward Antimicrobial Tert-Alkylamino CarbocyclesNational Institute Of Allergy And Infectious Diseases2008
Office
9500 Euclid Ave
Cleveland, OH 44195Phone+1 800-223-2273
